Kiara
Fairman
M.S., Pharm.D
Leadership Role
Research Biologist — Division of Biochemical Toxicology
Kiara Fairman, M.S., Pharm.D.
(870) 543-7121
NCTRResearch@fda.hhs.gov
Back to NCTR Principal Investigator page
About | Publications | Lab Members
Background
Dr. Kiara Fairman received a bachelor’s degree in chemistry from Alabama State University and a Master of Science in Biological Sciences – Chemistry Track from the University of Texas Southwestern Medical Center at Dallas. She received a Doctor of Pharmacy degree from the University of North Texas System College of Pharmacy in Fort Worth, TX, and holds a Certificate in Regulatory Science from the University of Arkansas Medical Sciences. Dr. Fairman was an Oak Ridge Institute for Science and Education (ORISE) postdoctoral fellow at FDA’s National Center for Toxicological Research (NCTR) from 2019 — 2021 and is currently a staff fellow in the Division of Biochemical Toxicology where she works on physiologically based pharmacokinetic modeling tools for regulatory decision making in pregnancy. Dr. Fairman has attended and presented at multiple conferences and annual meetings in the areas of clinical pharmacology, pharmacy, and chemistry.
In her professional career, Dr. Fairman has received honors and awards such as:
- Society of Toxicology Biological Modeling Specialty Section — Best Abstract Award (2021)
- Society of Toxicology Computational Toxicology Specialty Section — Postdoc Award (2021)
- Society of Toxicology South Central Chapter — 2nd Place Non-Student/Non-Faculty Platform Presentations (2020)
- American Chemical Society Division of Chemical Toxicology — Outstanding Poster Award
Research Interests
Dr. Fairman’s research interests are broad and include making physiologically based pharmacokinetic (PBPK) modeling widely available in clinical practice for individualized bedside medicine and using PBPK modeling for unique and underrepresented patient populations such as pregnancy, ethnicity, and disease state modeling. Dr. Fairman also desires to incorporate new advancements such as artificial intelligence (AI) and machine learning into PBPK modeling. Her current research goals are to learn AI and collaborate with AI experts to incorporate AI into a PBPK model for automation and model confidence building as a tool for regulatory use. Her expertise is in PBPK modeling, pharmacy, and chemistry and she is further interested in medicinal chemistry, natural products, and clinical pharmacology research.
Professional Societies/National and International Groups
American Association of Pharmaceutical Scientists
Member
2020 – 2021
American Chemical Society
Member
2019 – 2021
American College of Clinical Pharmacology
Member
2017 – 2021
American Society of Health-System Pharmacists
Member
2016 – 2020
Arkansas Pharmacist Association
Member
2019 – 2021
FDA Fellows Association
Social Media Representative Co-Chair
2019 – 2020
Jefferson Laboratories Fellows Advisory Committee
Member
2019 – 2021
Social Committee Member
2019 – 2020
Kappa Psi Pharmaceutical Fraternity
Member
2016 – 2019
Zeta Lambda Chapter Scholarship Chair & Historian
2016 – 2018
Society of Toxicology (SOT)
Member
2019 – 2021
Postdoctoral Association, SOT
Treasurer
2021 – Present
Risk Assessment Specialty Section, SOT
Postdoctoral Representative
2020 – 2021
Student National Pharmaceutical Association (SNPhA)
Member
2015 – 2019
National Power To End Stroke (PTES), SNPhA
Chair
2017 – 2018
University of North Texas Health Science Center Student Society of Health-System Pharmacists
Professional Development Co-chair
2017 – 2018
Selected Publications
Physiologically Based Pharmacokinetic (PBPK) Modeling of RNAi Therapeutics: Opportunities and Challenges.
Fairman K., Li M., Ning B., and Lumen A.
Biochem Pharmacol. 2021, 189:114468. doi: 10.1016/j.bcp.2021.114468. [Epub Feb 10, 2021].
Physiologically Based Pharmacokinetic Modeling: A Promising Tool for Translational Research and Regulatory Toxicology.
Fairman K., Li M., Kabadi S., and Lumen A.
Current Opinion in Toxicology. 2020, 23–24, 17-22. https://doi.org/10.1016/j.cotox.2020.03.001. [Epub Dec 31, 2013].
Lab Members
Contact information for all lab members:
(870) 543-7121
NCTRResearch@fda.hhs.gov
Me-Kyoung Choi, Pharm.D.
ORISE Fellow
Pavani Gonnabathula, Ph.D.
ORISE Fellow
Miao Li, Ph.D., Master of Medicine, DABT
Visiting Scientist
- Contact Information
- Kiara Fairman
- (870) 550-3793